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Abstract
Dosage compensation in mammals occurs at two levels. In addition to balancing X-chromosome
dosage between males and females via X-inactivation, mammals also balance dosage of Xs and
autosomes. It has been proposed that X-autosome equalization occurs by upregulation of Xa
(active X). To investigate mechanism, we perform allele-specific ChIP-seq for chromatin epitopes
and analyze RNA-seq data. The hypertranscribed Xa demonstrates enrichment of active chromatin
marks relative to autosomes. We derive predictive models for relationships among POL-II, active
mark densities, and gene expression, and suggest that Xa upregulation involves increased
transcription initiation and elongation. Enrichment of active marks on Xa does not scale
proportionally with transcription output, a disparity explained by nonlinear quantitative
dependencies among active histone marks, POL-II occupancy, and transcription. Significantly, the
trend of nonlinear upregulation also occurs on autosomes. Thus, Xa upregulation involves
combined increases of active histone marks and POL-II occupancy, without invoking X-specific
dependencies between chromatin states and transcription.
INTRODUCTION
In many organisms, sex is determined genetically by dimorphic sex chromosomes. In the
XY-based system, females are homogametic (XX) and males are heterogametic (XY)1,2
Current evolutionary theories suggest that sex chromosomes evolved from a pair of
autosomal homologues, and acquisition of favorable male genes on the Y led to a
suppression of recombination, making gradual loss of Y-chromosome material inevitable.
Degeneration of the Y would have resulted in a continual series of sudden changes in gene
dosage balance not only between male and female Xs, but also between X and autosomes 1.
Ohno predicted that two types of dosage compensation schemes must therefore exist 2-4. For
mammals, the existence of X-chromosome inactivation (XCI) to silence one of the two X
chromosomes in females has been known since 1961 5,6. This mechanism equalizes X-
chromosome dosage between the sexes and depends on expression of Xist RNA 7-9 coupled
with recruitment of PRC2 complex10-12 . But because XCI creates another level of dosage
imbalance, this one between X’s and autosomes of both sexes, a secondary compensatory
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tmechanism must target the active X chromosome (Xa) and double its transcription to restore
genome-wide balance.
Several recent studies support the idea of X hyperactivation in mammals. Microarray-based
gene expression profiling of mammalian tissues showed that X-linked genes are expressed
not at half the average autosomal dose (as would be expected if expression came from a
single X) but at nearly the same dose as autosomal genes in both sexes, implying that the Xa
is upregulated in both males and females 13,14. These conclusions have been challenged by
analysis of RNA-Seq data, which showed that the expression average of X-linked genes was
approximately half that of the autosomal average15 A more recent study, however, indicates
that this interpretation was confounded by inclusion of silent genes on the X 16.
Here, we take an alternate approach to address whether and how dosage compensation
occurs between X and autosomes by investigating chromatin signatures on a genome-wide
scale. We carry out allele-specific chromatin immunoprecipitation with deep sequencing
(ChIP-seq) for RNA polymerase II (POL-II) and activate chromatin marks and, through a
combined analysis with RNA-seq data, we find that Xa upregulation indeed occurs. The data
suggest that Xa upregulation occurs at the level of both transcription initiation and
elongation and point to nonlinear quantitative dependencies among active histone marks,
POL-II occupancies, and transcription output which are not X-specific and are part of a
genome-wide mechanism for quantitative control of gene expression.
RESULTS
Confirmation of Xa upregulation
To address how X-linked transcription compares to autosomal transcription in the female
soma and whether the differences, if any, could be explained by chromatin mechanisms, we
first compared average gene expression of all X-linked and autosomal genes using
previously published RNA-seq data from a mouse female fibroblast cell line 17. We
calculated gene expression levels as FPKM values (fragments per kilobase per million) for
non-overlapping RefSeq mouse genes using TopHat and Cufflinks methods, and found that
the total FPKM averages of haploid X and autosomal genes differed only by 22%. This
conclusion is consistent with the argument that Xa-hyperactivation does not occur 15.
However, the X-chromosome may harbor more silent genes than autosomes. Reasoning that
this difference could confound measurements of average transcriptional output, we
categorized genes with respect to their expression status (active vs inactive) and CpG
content (high vs low) at the promoters (Supplementary Fig. 1a). A natural FPKM cutoff of
~1.0 for actively expressed genes was suggested by the analyses of dependency between
gene expression and POL-II densities across the gene body (Supplementary Fig. 2, see
Methods). We observed that almost 57% of X-linked genes were of low CpG content at
promoters (LCP) with very little to no transcription (inactive). Indeed, when analysis of the
RNA-seq data was performed using only expressed genes, the X-chromosome showed 85%
higher mean expression than the average haploid autosome set, with 57% difference in
median values (Supplementary Table I). X-hypertranscription was apparent among both
active HCP and active LCP genes (Supplementary Fig. 1b). Differences between autosomal
and X-linked gene populations were highly significant (Supplementary Table I, Mann-
Whitney P-values; Supplementary Fig. 1c). Thus, in agreement with previous
reports 13,14,16, the mammalian X is dosage compensated with respect to autosomes.
Allelic ChIP-seq reveals enrichment of active histone marks and POL-II on Xa
Next, we asked whether X:A dosage compensation has a chromatin basis. Over the years,
genome-wide profiles of histone marks have been generated by ChIP-on-chip or ChIP-seq.
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tIn every case, the analysis was performed either in male cell lines 18,19 or in female lines
without the allele-specificity and sequencing depth necessary to distinguish Xa from Xi with
sufficient resolution20-22. Here, we performed high-resolution, allele-specific ChIP-seq in a
clonal F1 hybrid female mouse fibroblast line that carries one haploid chromosome set of
Mus musculus (mus) origin and a second haploid set of Mus castaneous (cast) origins. We
examined active chromatin signatures that are associated with the transcription start site
(TSS), including phospho-serine-5 RNA polymerase II (POL-II-S5P) and trimethylated
histone H3 at lysine 4 (H3K4me3), both of which are associated with transcription initiation;
we also examined signatures associated with transcription elongation through the gene body,
including phospho-serine-2 POL-II (POL-II-S2P) and trimethylated H3 at lysine 36
(H3K36me3) 23,24. By using paired-end sequencing, we could uniquely align 83-93% of the
17-28 million read-pairs to the genome, yielding 16.5-21.9 million uniquely aligned reads
per epitope (Supplementary Table II).
With ~22 million SNP and ~1 million insertion/deletion differences between mus and cast
genomes25, ~35% of all read-paired could be assigned to specific alleles. Analysis of
monoallelically expressed loci, including the Zim1/Peg3 imprinted domain (Fig. 1a and data
not shown), confirmed the allele-specific output of the ChIP-seq. As expected, active marks
were found on the paternally expressed Peg3 allele (cast) and the maternally expressed Zim1
allele (mus). Elsewhere in the genome, active marks were evenly distributed between
autosomal homologues, as expected (Fig. 1b). By contrast, on the X-chromosome, active
marks were predominantly on Xcast (Xa), consistent with occurrence of XCI.
To determine whether Xa-hypertranscription is reflected in enrichment of active chromatin
marks, we compared coverages on Xcast (Xa) with those on autosomes of M. castaneous
origin. When we calculated medians for coverage densities on active genes, Xa showed 31%
more POL-II-S5P and 24% more H3K4me3 coverage around the TSS; Xa also showed 20%
more POL-II–S2P and 9% H3K36me3 coverage on the gene bodies (Fig. 2; Supplementary
Table I). The enrichments were statistically significant in each category (Supplementary
Table I), except for POL-II-S2P and H3K36me3 on LCP active genes, presumably due to
smaller sample of LCP active genes on the Xa (n=72). Moreover, distributions of density
values for all marks followed a similar shape (Fig. 2), suggesting that enrichment of Xa
marks was global and could not be attributed to a distinct subset with exceptionally high
coverage.
Nonlinear dependencies between active chromatin marks and transcription output
Interestingly, the enrichment of POL-II and active histone marks on Xa relative to
autosomes was not proportional to the nearly 2-fold transcriptional upregulation on Xa (Fig.
2; Supplementary Table I). Indeed, the degree of epitope enrichment was much less than 2-
fold. To explain this disparity, we compared POL-II and histone mark densities against
transcription output genome-wide. Plotting POL-II-S2P against FPKM (transcription) values
revealed a good correlation between gene expression and the elongating form of POL-II, as
expected. It also demonstrated a natural separation of active genes from inactive ones
(Supplementary Fig. 2: dotted horizontal line, FPKM cutoff of ~1.0) regardless of gene
category (HCP, LCP, all genes). Therefore, in subsequent analyses, we used active genes of
all three categories to investigate the relationship between chromatin epitope and
transcription output.
The relationship between transcription output and chromatin epitopes is shown by
scatterplots and point densities for Xa (black line contours) and autosomal (color contours)
genes in pairwise comparisons between expression and various chromatin epitopes (Fig. 3
and Supplementary Fig. 3-4). For active HCP M. castaneus alleles, we found pronounced
dependencies between gene expression and POL-II-S5P, POL-II-S2P and active histone
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tmarks, regardless of whether they were X-linked or autosomal (Fig. 3a-d). Similar strong
dependencies were observed between POL-II-S5P and H3K4me3 densities, and between
POL-II-S2P and H3K36me3 densities (Fig. 3e-h). Similar trends were also found in the
populations of all active (HCP+LCP) and active LCP genes (Supplementary Fig. 3-4). These
data showed that Xa and autosomal genes are subject to similar quantitative relationships
between active chromatin marks/POL-II and transcription output.
These dependencies have several universal features that might provide general insight into
the mechanism of Xa upregulation. First, the relationships showed monotonic trends:
Increases in POL-II or active histone marks densities were accompanied by corresponding
average increases in gene expression. Second, the relationship was nonlinear, as an increase
in the input variable (e.g., POL-II-S5P or H3K4me3) resulted in a much higher increase in
the readout (e.g., expression). The relationship could be linearized by using log-log scale
transformation, which suggested a power-law relationship. This type of dependency is
consistent with previously published analysis of correlations between expression and histone
mark densities at promoters26. The only exceptions were H3K36me3 comparisons against
all other epitopes. For both Xa and autosomal genes, a log scale transformation better
linearized the trend for H3K36me3 (Fig. 3f,h and Supplementary Fig. 3-4), implying that
relatively smaller changes in H3K36me3 can produce large changes in transcription output.
The overall non-linearity suggests potential collective effects in the regulation of POL-II
occupancy, changes in chromatin state, and transcriptional activity. Importantly, the non-
linear nature of these dependencies allows for signal amplification: For example, a 20-30%
increase in POL-II density corresponds to a larger increase in gene expression (Fig. 3a,b).
Third, although Xa and autosomal genes obeyed a common trend of dependency between
gene expression and active chromatin/POL-II marks, the Xa scatterplot demonstrated
consistent, significant shifts along the autosomal trendline to higher positions on both x- and
y-axes (Fig. 3 and Supplementary Fig. 3-4), reflecting the generally higher levels of gene
expression, POL-II occupancy, and H3K4me3 and H3K36me3 deposition on Xa relative to
autosomes. In comparison to autosomes, Xa genes generally showed better correlations
between chromatin epitopes (Fig. 4a), possibly reflecting the generally greater Xa values.
Although ranges for these variables on Xa overlapped with autosomes, there was a clear
distinction between the two gene populations, consistent with the significant differences in
the means/medians of epitope density coverages (Supplementary Table I, Supplementary
Fig. 1c and Fig. 1b).
Taken together, these data enable us to draw several conclusions regarding Xa upregulation.
The similar nonlinear trends of relationships for Xa and autosomal genes suggest that Xa
upregulation might be explained by chromatin-based mechanisms that are generally used
throughout the genome. On both Xa and autosomes, nonlinearity of the dependencies
provide a mechanism for signal amplification. For example, Xa upregulation might be
explained simply by increased density of active epigenetic marks associated with increased
POL-II occupancy, rather than by Xa-specific rules governing the relationship between
histone marks, POL-II, and transcription. Our data also indicate that, unlike in fruitflies
where enhanced transcription elongation has been proposed to be the primary mode of Xa
upregulation27 the mammalian mechanism displays a strong influence of enhanced
transcription initiation, as both POL-II-S5P and H3K4me3 have ~30% increased coverage at
the TSS of active Xa genes. At the same time, however, mammalian Xa upregulation is also
associated with ~20% increase in POL-II-S2P and ~9% increase in H3K36me3 coverages
across gene bodies, implying that elongation is also facilitated on Xa. We therefore propose
that Xa upregulation involves both enhanced transcription initiation and elongation that
depend on increased trimethylation of H3K4 and H3K36, which amplify gene expression in
a nonlinear fashion (Fig. 4b).
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tXa hyperactivation is predictable without necessitating Xa-specific principles
We tested this hypothesis by deriving models of gene expression based on autosomal active
mark occupancy and applying these models to Xa. The resulting predictions of X-linked
gene expression showed accordance with the observed values (Pearson r=0.71)(Fig. 4c).
Moreover, autosomal models based on any combination of marks, when applied to an
individual autosome, produced the correlation between predicted and observed values
similar to that of Xa (Supplementary Table III; See Methods for details). These results
suggested that, firstly, quantitative relationships between active histone mark densities,
POL-II occupancy, and gene expression had predictive power, consistent with the results of
others26. Secondly, trends observed in autosomes were remarkably predictive of X-linked
gene expression. Together, these conclusions argue that Xa upregulation is governed by
principles that are not unique to X but are applicable throughout the genome.
DISCUSSION
We have tested the hypothesis of Xa upregulation using a novel, unbiased approach and
asked whether this arm of dosage compensation is based on chromatin mechanisms similar
to those observed on autosomes. By allele-specific ChIP-seq and RNA-seq analysis, we
conclude that dosage compensation of Xa does occur, in agreement with previously
published studies 13,14,16. The inability of a separate study15 to detect Xa upregulation stems
from inclusion of inactive genes. When we considered all genes regardless of expression
status, the average difference was masked by unusually high fraction of silent genes (genes
with low-CpG content) on the X. Earlier studies 13,14 also included both active and inactive
genes; however, microarrays have a lower dynamic range and it is likely that the analysis
heavily favored highly transcribed genes.
We then focused on potential mechanisms of Xa upregulation. By analyzing the genome-
wide allelic distribution of POL-II and active chromatin marks in the context of gene
expression17 we found that Xa was enriched for POL-II-S5P, POL-II-S2P, H3K4me3, and
H3K36me3 relative to the haploid autosome set. Scatterplots (Fig. 3 and Supplementary Fig.
3-4) showed a clear rightward and upward shift of Xa contours relative to autosomal
contours, along the autosomal trendline to the higher levels of active marks and expression.
However, the degree of POL-II enrichment on Xa and the coverage of active histone marks
did not scale proportionally with increased transcription output from Xa. This nonlinearity
enables signal amplification with small changes in chromatin structure and POL-II density.
An unexpected observation was that the nonlinear dependencies applied to autosomes and X
alike, as suggested by all pairwise plots (Fig. 3 and Supplementary Fig. 3-4) and by the
quality of predicting Xa genes based on the autosome-based models (Fig. 4c and
Supplementary Table III). The similar quantitative relationships suggest that chromatin-
based processes governing Xa upregulation are used genome-wide, and that dosage
compensation of Xa and autosomes do not require X-specific principles to bring about the
~2-fold upregulation. Importantly, while the non-linear power laws apply to both Xa and
autosomes, we do not exclude the possibility that Xa-specific factors are required to initiate
the chromatin-based enhancement. Such factors could target Xa to a special compartment or
lead to association with nuclear pore factors, as has been suggested for Drosophila
melanogaster 28.
Our data imply similarities and differences with Xa upregulation in the fruitfly. In D.
melanogaster, the X-chromosome dosage between XX and XY individuals is equalized by
hypertranscription of the single male X-chromosome29-31. With this mechanism, the fly
compensates for differences between X and autosomal gene dosage at the same time it
achieves male-to-female X-chromosome balance. This process requires cooperation between
MOF histone acetyltransferase32, MSL complexes33-35, and the long noncoding RNA, roX1
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tand roX2 36,37. Together, they bring about precise chromatin change leading to ~2-fold
upregulation of the male X 27,38-45. An alternative mechanism proposes less dependency on
MSL-driven hyperactivation and more on the genome’s inherent ability to correct for dosage
imbalances – via the so-called “inverse effect” 32,46. This mechanism may also operate in
mammalian Xa upregulation.
X hyperactivation in the fruitfly has been proposed to be achieved primarily through
enhanced transcription elongation 27,38,43-45. In our system, differences in distributions of
POL-II-S5P, POL-II-S2P, H3K4me3, and H3K6me3 argue that Xa upregulation is
controlled through transcription initiation, but enhancement of elongation is also a strong
possibility. While POL-II-S5P and H3K4me3 coverages increase ~30% at the TSS of Xa
genes, POL-II-S2P and H3K36me3 coverages also increase ~20% and ~9%, respectively,
across gene bodies. In conclusion, we favor a model in which Xa upregulation is effected by
both enhanced transcription initiation and elongation via nonlinear dynamics. Future studies
will focus on whether and how Xa-specific factors might be involved in initiating
hypertranscription through the chromatin-based mechanisms identified herein.
METHODS
Cell line
To generate EY.T4 clonal hybrid cell line, female mice of Mus musculus (129S1) and male
mice of Mus castaneus (CAST/EiJ) origins were crossed, F1 embryos were collected at day
13.5 and mouse embryonic fibroblasts (MEFs) were prepared using female embryos. MEFs
were later immortalized by SV-40 T-antigen47 subcloned by limiting dilution, and the
chromosome content of each subclone was screened by DNA FISH using chromosome
paints and RNA FISH using Xist RNA probe.. In this clone, Xi was of Mus musculus and
Xa was of Mus castaneus origins as determined by allele-specific RT-PCR using primers
against Xist locus.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as described48 using 2×106 cells and 5-10μg of antibodies per reaction.
Antibodies used were as follows: H3K36me3 (ab9050, Abcam), H3K4me3 (ab8580,
Abcam), POL-II-S5P (ab5131, Abcam) and POL-II-S2P (ab5095, Abcam) and IgG rabbit
serum (I8140, Sigma). ChIP [DNA] was quantitated using Quant-iT Picogreen dsDNA
Assay kit (Invitrogen). ChIP products for H3K4me3 and H3K36me3 were verified by PCR
using primers against c-fos and c-jun genes.
ChIP library preparation and sequencing
Paired-end Solexa ChIP libraries were prepared as described in Illumina ChIP sequencing
manual with minor modifications and using NEB Next DNA sample prep reagent Set 1
(E6000S) (NEB). Input DNA was used as a control and for normalization. Modifications to
the Illumina protocol were: 1-30 ng of ChIP products were used as template, 2-paired-end
adapters were ligated to end-repaired and A-tailed DNA using T4 DNA ligase (NEB) for 2
hours at 16°C, and 2-Phusion polymerase in GC buffer (Finzyme) was used instead of
Phusion polymerase in HF buffer. DNA products were purified with QIAquick spin columns
(Qiagen). Concentration, size distribution (400-500bp), and purity of libraries were assessed
on DNA1000 Bioanalyzer chip (Agilent). Genome Analyzer II (Illumina) was used to
perform 2×36 cycles of paired end sequencing.
Calculation of allele-specific ChIP-seq coverage
Paired-end reads (17-28 million per sample, Supplementary Table II) were aligned to two
variant strain genomes (CAST/EiJ and 129S1/SvImJ) of the hybrid EY.T4 cell line. The
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tstrain genomes were reconstructed from mm9 reference using catalogued SNPs and indels25.
Resulting allelic differences include ~22 million SNPs and ~1 million indels, approximately
one modification per 120 bp. Alignment was performed with Novoalign 2.06
(www.novocraft.com) using default parameters with modifications: -i 300 100 –t 180 –R 10
–h 180 180 –v 180., Uniquely aligned pairs with significant score difference between the
two strain alignments (>10) were classified as allele-specific and assigned to the higher-
scoring allele variant; otherwise they were classified as neutral. Coverage was calculated
separately for allelic tracks (cast, mus) and composite track (allelic and neutral combined)
based on fragments defined by paired reads (~400 bp on average), discarding duplicate
fragments. Positional coverage was normalized input coverage with a pseudocount of 1 and
balanced for potential inequality of total input and experiment coverages: nnorm = [(n+1)/
(ni+1)] * [Ni/N], where n, ni, are positional coverages and N, Ni are total genome coverages
in experiment and input, respectively. For each promoter region and gene body, allelic skew
was estimated as the proportion of cumulative coverages at allelic cast/mus tracks, and
corresponding fractions of composite coverage were used in further analyses.
Gene set selection
To ensure unique representation of each gene and exclude alternative transcripts, mm9
RefSeq genes were grouped into single-linkage clusters by gene body overlap and the
longest gene in each cluster was chosen as a representative. Promoter regions were defined
as segments including +/− 3kb from annotated TSS with high- and low-CpG promoters
defined by the presence of CpG islands within 1 kb from the promoter. CpG islands were
identified by using EMBOSS 6.3.149 on unmasked mm9 genome with default parameters.
Estimation of gene expression levels
Approximately 45 million of 36-bp RNA-seq reads by Yang et al. 17 (NCBI SRA accession
SRA010053) were aligned to mm9 genome using TopHat50 with default parameters, except
for using arguments --no-novel-juncs and --min-isoform-fraction 0. The resulting alignments
were used to calculate FPKM (fragments per kilobase per million) values using Cufflinks51
with default parameters, except for setting --min-isoform-fraction 0. To estimate expression
from a single allele, autosomal expression values were divided by 2, whereas X-linked
expression values were used in full, given the well-documented inactivation of one X
chromosome. As a cutoff for active expression, we chose FPKM of 1.0 corresponding to the
boundary between two regimes of FPKM correlation to POL-II density on a gene (Fig. S2):
the absence of dependency at low values, consistent with readout fluctuations for silent
genes, and positive correlation at higher values, consistent with active transcription.
Choosing FPKM cutoff of 0 produced similar values.
Linear models of gene expression
Log-transformed mark densities on autosomes (POL-II on promoters and gene bodies,
H3K4me3 on promoters) and untransformed H3K36me3 on gene bodies were used for
training a linear regression model that predicts logarithm of gene expression. This model
(full model) was applied to the coverage densities on X chromosome, and the resulting
expression predictions for X-linked genes were compared to the observed values.
To compare prediction accuracy for X chromosome and for an individual autosome, we
trained and tested 19 models in a chromosome-based cross-validation setting. Specifically, a
model (partial model) was trained on the autosomal gene set with one autosome removed
and applied separately to the removed autosome and X chromosome. Pearson correlation
coefficients between predicted and observed logarithms of expression for X chromosome
were compared to the distribution of Pearson R for 19 autosomes. This comparison was
made for the models based on all possible combinations of marks as predictors.
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alleviate this problem, we used two approaches. First, we added a pseudocount of 1.0 to
each value x so that log (x+1) was calculated. Second, since the fraction of zero values
among actively expressed genes was relatively low we tested the removal of genes with zero
values from the dataset. Both approaches produced similar results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Allele-specific ChIP-seq
(a) Profiles for POL-II-S5P, H3K4me3, and H3K36me3 are mapped to M. castaneous (cast)
or M. musculus (mus) alleles for two imprinted loci, Zim1 52 and Peg3 53 on Chromosome
7. Composite tracks (comp) represent combination of cast, mus and neutral reads. Coverage
values are normalized by input and are indicated on the y-axis. (b) X chromosome shows a
strong allelic skew in the occupancy of active histone marks and POL-II at the TSS and
across the gene body. Barplots show mean composite densities of H3K4me3, H3K36me3,
POL-II-S2P and POL-II-S5P on autosomes (A) and X chromosome (X), with proportion of
allelic coverage indicated by red (cast), and blue (mus) fractions. Inactive X (Xmus), and
active X (Xcast).
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tFigure 2. Distributions of coverage densities for POL-II and active histone modifications on X
chromosome and autosomes
Coverage density values are shown for H3K4me3 and POL-II-S5P at the TSS and for
H3K36me3 and POL-II-S2P across the gene bodies as indicated. Distributions are plotted
for actively transcribed (HCP+LCP, HCP and LCP) genes. Black line, autosomal genes; red
line, X-linked genes.
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tFigure 3. Relationships between levels of gene expression, POL-II, and active histone
modifications
M. castaneous alleles of actively expressed autosomal HCP genes are represented as points,
with point density shown by colored contour. Black line contour represents active HCP X-
linked M. castaneous alleles (Xa). Expression, POL-II, and histone modification levels are
positively correlated, the relationships are non-linear, and X-linked genes follow autosomal
trends of dependency, albeit with a shift to higher values. (a,b) POL-II at the TSS (a) and
across the gene body (b) vs expression (log-log scale). (c) H3K4me3 at the TSS vs
expression (log-log scale). (d) H3K36me3 across the gene body vs expression (linear-log
scale). (e) H3K4me3 vs POL-II at the TSS (log-log scale). (f) H3K36me3 across the gene
body vs POL-II at the TSS (linear-log scale). (g) H3K4me3 at the TSS vs POL-II across the
gene body (log-log scale). (h) H3K36me3 vs POL-II across the gene body (linear-log scale).
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tFigure 4. Autosomal relationships between active histone modifications, POL-II, and expression
are predictive of X-linked gene expression
(a) Actively expressed X-linked and autosomal genes show similar patterns of correlation
between the levels of active marks and expression. Pearson correlation coefficients between
the levels of all marks and expression (FPKM) are shown as heatmaps for actively expressed
(HCP+LCP, HCP, and LCP) genes. In each plot, autosomal and X chromosome correlations
are shown above and below diagonal, respectively. (b) Active X chromosome loci (X) and
the corresponding set of autosomal loci (A) show similar non-linear relationship between
active marks and expression (blue curve), which produces a large average expression change
in response to smaller changes in the mark occupancy (schematic). (c) Scatterplot of X-
linked gene expression values predicted from autosome-based full linear model vs observed
X-linked expression (log-log scale). Shades of blue indicate point density. Identity line y=x
is shown in red.
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